Skip to main content

Abstract

This chapter discusses how to measure and evaluate the values in health-care decisions. The values of health-care decisions can be measured by health outcomes. The measured health outcomes are classified into clinical outcomes, humanistic outcomes, and economic and utilization outcomes. The clinical outcomes are the most commonly used health outcomes in comparative effectiveness research. However, evaluating the values of health-care decisions requires the economic and utilization outcomes (costs) also.

The values in health-care decisions can be evaluated to determine whether a health-care decision is an efficient use of society’s resources. The economic evaluation methods are classified into the cost-health outcome evaluations and cost-only evaluations. The former included cost-effectiveness analysis, cost-utility analysis, cost-consequence analysis, and cost-benefit analysis, and the latter included cost-minimization analysis and cost-of-illness/cost-identification analyses.

The most common type of economic evaluation is the cost-effectiveness analysis (including cost-utility analysis) that compares the costs and outcomes of alternative approaches to reaching the “same” objective in order to determine which alternative accomplishes a given objective at the least cost. The cost-benefit analysis can compare widely varying programs and services with different outcomes to evaluate allocative efficiency among interventions between health care and other sectors. Cost-of-illness/cost-identification analyses estimate economic burdens of disease or treatment on society. Cost-minimization analysis identifies the least expensive alternative to minimize cost with an assumption of identical effectiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Porter ME (2010) What is value in health care? N Engl J Med 363(26):2477–2481

    Article  CAS  PubMed  Google Scholar 

  2. Samuelson PA, Nordhaus WD (2010) Economics, vol xxiv, 19th edn, The McGraw-Hill series economics. McGraw-Hill Irwin, Boston, p 715

    Google Scholar 

  3. Drummond M (2005) Methods for the economic evaluation of health care programmes, 3rd edn, Oxford medical publications. Oxford University Press, Oxford, New York, p 379

    Google Scholar 

  4. Motheral B (1997) Outcomes management: the why, what, and how of data collection. J Manag Care Pharm 3:345–351

    Google Scholar 

  5. Kozma CM, Reeder CE, Schulz RM (1993) Economic, clinical, and humanistic outcomes: a planning model for pharmacoeconomic research. Clin Ther 15(6):1121–1132; discussion 1120

    CAS  PubMed  Google Scholar 

  6. Gunter MJ (1999) The role of the ECHO model in outcomes research and clinical practice improvement. Am J Manag Care 5(4 Suppl):S217–S224

    CAS  PubMed  Google Scholar 

  7. Priscilla Velentgas P et al (eds) (2013) Developing a protocol for observational comparative effectiveness research: a user’s guide. Agency for Healthcare Research and Quality (US), Rockville

    Google Scholar 

  8. Herman CR et al (2013) Development of a predictive model for major adverse cardiac events in a coronary artery bypass and valve population. J Cardiothorac Surg 8(1):177

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion, Healthy People 2020; Health-Related Quality of Life and Well-Being, Washington, DC

    Google Scholar 

  10. Guyatt GH, Feeny DH, Patrick DL (1993) Measuring health-related quality of life. Ann Intern Med 118(8):622–629

    Article  CAS  PubMed  Google Scholar 

  11. MacKinnon GE (2011) Understanding health outcomes and pharmacoeconomics. Jones and Bartlett Publishers, Burlington, MA

    Google Scholar 

  12. U.S. Department of Health and Human Services, Food and Drug Administration (2009) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Available at http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf

  13. Stamuli E (2011) Health outcomes in economic evaluation: who should value health? Br Med Bull 97:197–210

    Article  PubMed  Google Scholar 

  14. Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5(1):1–30

    Article  CAS  PubMed  Google Scholar 

  15. Torrance GW (1987) Utility approach to measuring health-related quality of life. J Chronic Dis 40(6):593–603

    Article  CAS  PubMed  Google Scholar 

  16. Feeny D et al (1995) Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics 7(6):490–502

    Article  CAS  PubMed  Google Scholar 

  17. Feeny D et al (2004) Comparing directly measured standard gamble scores to HUI2 and HUI3 utility scores: group- and individual-level comparisons. Soc Sci Med 58(4):799–809

    Article  PubMed  Google Scholar 

  18. The EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 16(3):199–208

    Google Scholar 

  19. Brazier J et al (2008) Estimation of a preference-based index from a condition-specific measure: the King’s Health Questionnaire. Med Decis Making 28(1):113–126

    Article  PubMed  Google Scholar 

  20. Lenert L, Kaplan RM (2000) Validity and interpretation of preference-based measures of health-related quality of life. Med Care 38(9 Suppl):II138–II150

    CAS  PubMed  Google Scholar 

  21. Cheng Y et al (2013) Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review. Res Social Adm Pharm 9(3):311–329

    Article  PubMed  Google Scholar 

  22. Segel JE (2006) Cost-of-illness studies—A primer. RTI-UNC Center of Excellence in Health Promotion Economics, pp 1–39

    Google Scholar 

  23. Cellini SR, Kee JE (2010) Cost-effectiveness and cost-benefit analysis. Handbook of practical program evaluation. Jossey-Bass, San Francisco, CA, p 493

    Google Scholar 

  24. Consumer price index- all urban consumers (2014) [cited 17 Dec 2014]. Available from: http://www.bls.gov/data

  25. OECD. StatExtracts. Purchasing Power Parities (PPP) Statistics (2014) [cited 17 Dec 2014]. Available from: http://stats.oecd.org/

  26. Ramsey SD, Willke RJ, Glick H, et al (2015) Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 18(2):161–172

    Google Scholar 

  27. Robinson R (1993) Economic evaluation and health care. What does it mean? BMJ 307(6905):670–673

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Kattan M et al (2005) Cost-effectiveness of a home-based environmental intervention for inner-city children with asthma. J Allergy Clin Immunol 116(5):1058–1063

    Article  PubMed  Google Scholar 

  29. Bootman JL, Townsend RJ, McGhan WF (2005) Principles of pharmacoeconomics, vol x, 3rd edn. Harvey Whitney Books Co, Cincinnati, p 409

    Google Scholar 

  30. Briggs AH et al (2010) Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. Eur Respir J 35(3):532–539

    Article  CAS  PubMed  Google Scholar 

  31. Russell LB et al (1996) The role of cost-effectiveness analysis in health and medicine. JAMA 276(14):1172–1177

    Article  CAS  PubMed  Google Scholar 

  32. Mauskopf JA et al (1998) The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 13(3):277–288

    Article  CAS  PubMed  Google Scholar 

  33. Kroese ME et al (2011) Specialized rheumatology nurse substitutes for rheumatologists in the diagnostic process of fibromyalgia: a cost-consequence analysis and a randomized controlled trial. J Rheumatol 38(7):1413–1422

    Article  PubMed  Google Scholar 

  34. Runge C et al (2006) Outcomes of a web-based patient education program for asthmatic children and adolescents. Chest 129(3):581–593

    Article  PubMed  Google Scholar 

  35. Dasta JF et al (2010) A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 38(2):497–503

    Article  PubMed  Google Scholar 

  36. Koopmanschap MA (1998) Cost-of-illness studies. Useful for health policy? Pharmacoeconomics 14(2):143–148

    Article  CAS  PubMed  Google Scholar 

  37. Akobundu E et al (2006) Cost-of-illness studies : a review of current methods. Pharmacoeconomics 24(9):869–890

    Article  PubMed  Google Scholar 

  38. Byford S, Torgerson DJ, Raftery J (2000) Economic note: cost of illness studies. BMJ 320(7245):1335

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  39. Tarricone R (2006) Cost-of-illness analysis: what room in health economics? Health Policy 77(1):51–63

    Article  PubMed  Google Scholar 

  40. Shiell A, Gerard K, Donaldson C (1987) Cost of illness studies: an aid to decision-making? Health Policy 8(3):317–323

    Article  Google Scholar 

  41. Stock S et al (2005) Asthma: prevalence and cost of illness. Eur Respir J 25(1):47–53

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minchul Kim PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Kim, M., Asche, C.V., Kim, I.K. (2016). The Question of Value. In: Asche, C. (eds) Applying Comparative Effectiveness Data to Medical Decision Making. Adis, Cham. https://doi.org/10.1007/978-3-319-23329-1_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-23329-1_6

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-22064-2

  • Online ISBN: 978-3-319-23329-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics